I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Three Bispecific Antibody Programs Life Science
China News Weekly 79 – MeMed Raises Over $70 Million to Advance Pioneering Point-Of-Care Platform and Immune-Based Test for Distinguishing Bacterial Versus Viral Infections Life Science, Mining, Technology
$80 Million Series B Financing Funds Morphic Therapeutic’s Next-Generation Oral Integrin Life Science
VenatoRx Pharmaceuticals and Everest Medicines II Limited Announce Exclusive License Agreement for cefepime/VNRX-5133 Life Science
British Biologicals’ USA Leadership Team Equipped for Launch of NEW California Based Operating Facility Life Science
Kalorama Information Reports IVD Markets in China, South Korea and Vietnam Reach $3.7 Billion Life Science
NAI wishes you a happy Mid-Autumn Festival! Energy, Financial Service, Life Science, Mining, Technology
Bay Area’s uBiome Secures $83 Million as It Moves into Drug Development, Taps ex-Novartis CEO for Its Board Life Science
Acadia Pharma Soars After FDA Investigation Clears Nuplazid of Additional Safety Problems Life Science
MeMed Raises Over $70 Million to Advance Pioneering Point-Of-Care Platform and Immune-Based Test for Distinguishing Bacterial Versus Viral Infections Life Science
